| Cancer | SIR in people with HIV/AIDS | SIR in transplant recipients |
| Lymphoproliferative and hematologic malignancies | ||
| Non-Hodgkin lymphoma | 22.6-353.5 | 5.5-9.9 |
| Hodgkin lymphoma | 3.6-18.0 | 2.2-8.0 |
| Multiple myeloma | 2.2-5.0 | 2.7-3.8 |
| Leukemia | 1.8-5.3 | 2.3-2.5 |
| Cutaneous malignancies | ||
| Kaposi sarcoma | 3640 | 208 |
| Skin carcinoma | 1.5-19.6 | 10.7-56.2 |
| Melanoma | 0.2-1.3 | 1.4-2.5 |
| Eye cancer | 1.7-2.0 | 2.0-7.6 |
| Genitourinary malignancies | ||
| Cervical cancer | 1.0-22.0 | 1.5-2.5 |
| Vulvar/vaginal cancer | 4.4-6.8 | 22.2-23.9 |
| Ovarian cancer | 0.3-4.4 | 1.2-2.0 |
| Uterine cancer | 0.5-0.9 | 0.9-1.7 |
| Breast cancer | 0.7-1.4 | 1.0-1.5 |
| Penile cancer | 3.9-8.0 | 15.8 |
| Testicular cancer | 0.7-1.8 | 1.3-2.3 |
| Prostate cancer | 0.5-1.4 | 0.9-1.1 |
| Renal cancer | 0.8-2.0 | 4.1-8.0 |
| Bladder cancer | 0.4-4.2 | 1.6-3.3 |
| Gastrointestinal malignancies | ||
| Anal cancer | 19.6-50.0 | 2.8-10.3 |
| Liver cancer | 1.9-22.2 | 1.1-3.2 |
| Small intestine cancer | 1.3-3.4 | 1.1-11.8 |
| Stomach cancer | 0.4-2.9 | 1.8-2.3 |
| Pancreatic cancer | 0.7-2.9 | 0.9-1.2 |
| Colorectal cancer | 0.9-1.4 | 1.4-2.1 |
| Esophageal cancer | 0.5-2.1 | 1.6-3.8 |
| Respiratory tract tumors | ||
| Respiratory tract (lower) cancer | 1.4-4.5 | 1.7-2.1 |
| Oropharyngeal cancer | 1.1-2.9 | 2.8-5.3 |
| Laryngeal cancer | 0.6-2.8 | 1.7-2.5 |
| Lip cancer | 2.3-3.1 | 13.0-53.3 |
| Miscellaneous | ||
| Thyroid cancer | 0.4-3.0 | 0.9-8.1 |
| Brain cancer | 0.5-4.4 | 0.6-1.4 |
